Compare HCA Health Inc (HCA) vs MasterCard Inc (MA) Price & Performance

HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.

The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.

Mastercard (MA) trades at $545.00, up 0.26% today, with strong technical support at $540 and resistance at $547. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding expectations of $4.41. Revenue grew to $32.79B in 2025, and net income margin remains high at 45.88%. Analysts maintain a bullish consensus with a $634.27 price target, citing momentum in digital payments and AI integration.

Outlook remains positive given consistent earnings outperformance and strategic initiatives in AI and financial inclusion. Key risks include competitive disruption from stablecoins and elevated valuation multiples. Institutional ownership trends show continued accumulation, supporting the bullish sentiment. The stock presents a growth opportunity but requires monitoring of payment industry evolution and valuation sustainability.